EUVIMEDEUVIMED entdecken
Crossref

Anti‐arrhythmic targeting of sympathetic stellate ganglion P2X3 receptors

Carol T Bussey, Harvey Davis, Emma L Bogert, Ruirui Dong, Dan Li, Jichao Ma, Maximillian C D Gerber, Zixi Cheng, Martin K Stiles, David J Paterson, Julian F R Paton

The Journal of Physiology · 2026-02 · 604 (3) · 1067-1087

DOI: 10.1113/jp290004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Physiology, online erschienen am 31.12.2025. Verfasst von Carol T Bussey und 10 weiteren Autor:innen. Beteiligte Einrichtung: Manaaki Manawa - The Centre for Heart Research, Department of Physiology, Faculty of Medical & Health Sciences, University of Auckland, Auckland, New…. Hauptthemen laut MEDLINE: Stellate Ganglion, Receptors, Purinergic P2X3, Arrhythmias, Cardiac, Anti-Arrhythmia Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 78 Literaturangaben. Gefördert von: Health Research Council of New Zealand, BHF, Sidney Taylor Trust and is a Partridge research laureate.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sympathetic hyperactivity associated with many primary cardiovascular diseases is pro‐arrhythmic and a key contributor to sudden cardiac death. Surgically removing the sympathetic stellate ganglion has demonstrated therapeutic potential in minimising cardiac arrhythmia, but there are off‐target risks prompting the need for more site‐specific non‐invasive approaches. Here we hypothesised that P2X3 purinergic receptors (P2X3R) may be a therapeutic target and play a role in the excessive sympathetic drive to the heart in cardiovascular disease. We investigated the role of P2X3R in the sympathetic stellate ganglion of Wistar and spontaneously hypertensive rats, and human‐induced pluripotent stem cell (hiPSC)‐derived sympathetic neurons, using a combination of immunohistochemistry, qRT‐PCR, and in vitro calcium fluorescence imaging. Responses to ATP and P2X3R inhibition were investigated in intact stellate ganglion–heart preparations in situ . We confirm expression of P2X3R in sympathetic neurons of rat stellate ganglia at mRNA and protein levels. P2X3R mRNA was upregulated in SHR stellate ganglia compared to Wistar. Activation of P2X3R increased [Ca 2+ ] i in both isolated post‐ganglionic sympathetic stellate neurons and hiPSC‐derived sympathetic neurons, whereas microinjection of αβ‐methylene ATP directly into right stellate ganglia induced tachycardia. Attenuation of these responses by a selective antagonist (AF353) indicated the tachycardia was P2X3R mediated. Inhibition of P2X3R rapidly restored the normal heart rhythm from sympathetic‐induced cardiac arrhythmia. We show that stellate ganglion P2X3R contribute to sympathetically mediated cardiac chronotropic regulation. Our findings highlight the potential for inhibition of P2X3R located in the sympathetic stellate ganglion as a promising novel therapeutic for sympathetic nervous system‐induced cardiac arrhythmias. image Key points Sympathetic nerve overactivity is pro‐arrhythmic and a key contributor to left ventricular tachycardia and sudden cardiac death. P2X3 purinergic receptors are upregulated in stellate ganglia from prehypertensive rats. Stellate ganglion P2X3 receptors mediate increases in neuronal intracellular calcium and heart rate. Inhibiting P2X3 receptors rapidly and profoundly recovers normal heart rhythm from arrhythmia, highlighting the potential for inhibition of P2X3 receptors as a novel anti‐arrhythmic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stellate GanglionReceptors, Purinergic P2X3Arrhythmias, CardiacAnti-Arrhythmia AgentsAnimalsRats, WistarRatsRats, Inbred SHRMaleHumansInduced Pluripotent Stem CellsNeuronsAdenosine TriphosphatePurinergic P2X Receptor Antagonists

Stichwörter der Autor:innen

ATPP2X3 purinergic receptoranti‐arrhythmic agentcardiac arrhythmiaratsympathetictachycardia

Substanzen

Receptors, Purinergic P2X3Adenosine TriphosphatePurinergic P2X Receptor AntagonistsAnti-Arrhythmia Agents

Autor:innen und Institutionen

  • Manaaki Manawa - The Centre for Heart Research, Department of Physiology, Faculty of Medical & Health Sciences, University of Auckland, Auckland, New Zealand.
  • Burdon Sanderson Cardiac Science Centre, Department of Physiology, Anatomy and Genetics, Medical Sciences Division, University of Oxford, Oxford, UK.
  • Institute of Electrophysiology, Henan Academy of Innovations in Medical Science, Zhengzhou, China.
  • Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, Florida, USA.
  • Waikato Clinical School, Faculty of Medical & Health Sciences, University of Auckland, Hamilton, New Zealand.

Förderung

  • Health Research Council of New Zealand
  • BHF
  • Sidney Taylor Trust and is a Partridge research laureate
  • British Heart Foundation

Zitieren

APA

Bussey, C. T., Davis, H., Bogert, E. L., Dong, R., Li, D., Ma, J., Gerber, M. C. D., Cheng, Z., Stiles, M. K., Paterson, D. J., & Paton, J. F. R. (2026). Anti‐arrhythmic targeting of sympathetic stellate ganglion P2X3 receptors. The Journal of Physiology, 604(3), 1067-1087. https://doi.org/10.1113/jp290004

Vancouver

Bussey CT, Davis H, Bogert EL, Dong R, Li D, Ma J, et al. Anti‐arrhythmic targeting of sympathetic stellate ganglion P2X3 receptors. The Journal of Physiology. 2026;604(3):1067-1087. doi:10.1113/jp290004

BibTeX
@article{Bussey2026,
  author = {Bussey, Carol T and Davis, Harvey and Bogert, Emma L and Dong, Ruirui and Li, Dan and Ma, Jichao and Gerber, Maximillian C D and Cheng, Zixi and Stiles, Martin K and Paterson, David J and Paton, Julian F R},
  title = {Anti‐arrhythmic targeting of sympathetic stellate ganglion P2X3 receptors},
  journal = {The Journal of Physiology},
  year = {2026},
  volume = {604},
  number = {3},
  pages = {1067--1087},
  doi = {10.1113/jp290004}
}
Kostenlos starten →